Cancel
Chinglin Lai
Senior Vice President of Biostatistics and Data Management
@
Apollomics
eb16ty6y.b86@r9dz9ejb7ztuq.vbd
Sign up to see email
Known information
- Joined Apollomics in 2021 as the Senior Vice President of Biometrics
- Has over 27 years of experience in drug development across a broad range of therapeutic areas
- Was a consultant providing statistical expertise to over 20 emerging and established pharmaceutical and biotech companies in the US and Asia
- Held leadership positions at Jazz Pharmaceuticals, overseeing biostatistics, statistical programming, and data management functions for all portfolio products
- Worked at Intrabiotics Pharmaceuticals (2004-2005) and was a member of the core team for evaluating in-licensing opportunities
- Contributed to the marketing approvals of 5 products in the US and EU while at Alza Corporation
- Received a B.S. in Mathematics from National Central University in Taiwan
- Earned a Ph.D. in Applied Statistics from the University of California, Riverside, with a concentration in experimental design
About Apollomics
Apollomics is a biopharmaceutical company focused on developing innovative oncology therapies, including targeted treatments and immune system enhancers, with operations in the U.S., China, and Australia.
Report inaccurate information
